首页> 外文期刊>Der Pharma Chemica: journal for medicinal chemistry, pharmaceutical chemistry and computational chemistry >Revealing the J-coupling in the 1H-NMR Spectra of Antineoplastic and Antimetabolites Drugs
【24h】

Revealing the J-coupling in the 1H-NMR Spectra of Antineoplastic and Antimetabolites Drugs

机译:在抗肿瘤药和抗代谢药的1H-NMR光谱中揭示J偶联

获取原文
           

摘要

Pyrimidines have a long and distinguished history extending from the days of their discovery as important constituents of nucleic acids to their current use in the chemotherapy of cancer. This heterocyclic moiety has great biological and medicinal significance. There are 12 compounds in PubChem database which come in a category of antimetabolites and antineoplastic, and follow the Lipinski rule of five. Since, PubChem have no spectral information of any compound, we examined the theoretical 1H spectral of these categorized compounds and described the relevance of pyrimidine ring and presence of J-J coupling in the structure of these drug compounds.
机译:嘧啶具有悠久而独特的历史,从发现它们作为核酸的重要成分开始,一直到目前在癌症化学疗法中的用途。该杂环部分具有重要的生物学和医学意义。 PubChem数据库中有12种化合物属于抗代谢物和抗肿瘤药,并且遵循Lipinski规则中的5种。由于PubChem没有任何化合物的光谱信息,因此我们检查了这些分类化合物的理论1H光谱,并描述了嘧啶环的相关性和这些药物化合物结构中J-J偶联的存在。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号